Back to Companies
Benitec Biopharma Inc.
BNTCNasdaqCIK: 0001808898
Recent Form 4 activity at Benitec Biopharma Inc. (BNTC) spans 14 filings across 9 insiders (all of them on the buy side). Purchases total $22.4M against $0 in sales — heavily weighted toward buying, for a net purchase of $22.4M. SUVRETTA CAPITAL MANAGEMENT, LLC is the most active by dollar volume, and the single largest transaction was $20.0M by SUVRETTA CAPITAL MANAGEMENT, LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$40.1M
Purchases
$22.4M
Sales
$0
Unique Insiders
9
Recent Insider Trades
14 loaded
| Jun 30 | BNTC Benitec Biopharma Inc. | BUCHI J KEVIN | Insider | Gift | $0 |
| May 28 | BNTC Benitec Biopharma Inc. | Friedman David Matthew | Insider | Award | $400.8K |
| May 28 | BNTC Benitec Biopharma Inc. | Friedman David Matthew | Insider | Other | $0 |
| Jan 26 | BNTC Benitec Biopharma Inc. | Mates Sharon | Director | Award | $404.1K |
| Dec 29 | BNTC Benitec Biopharma Inc. | SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | Buy | $1.9M |
| Dec 22 | BNTC Benitec Biopharma Inc. | SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | Buy | $539.0K |
| Dec 3 | BNTC Benitec Biopharma Inc. | Francis Peter | Director | Award | $428.1K |
| Dec 3 | BNTC Benitec Biopharma Inc. | Mates Sharon | Director | Award | $42.8K |
| Dec 3 | BNTC Benitec Biopharma Inc. | Mehta Kishan | Director | Award | $428.1K |
| Dec 3 | BNTC Benitec Biopharma Inc. | BUCHI J KEVIN | Director | Award | $428.1K |
| Nov 20 | BNTC Benitec Biopharma Inc. | Boston Megan | Chief Financial Officer, Director | Award | $2.7M |
| Nov 20 | BNTC Benitec Biopharma Inc. | Mukadam Sophie | Chief Operating Officer | Award | $6.8M |
| Nov 20 | BNTC Benitec Biopharma Inc. | Banks Jerel A. | Chief Executive Officer, Director | Award | $6.1M |
| Nov 10 | BNTC Benitec Biopharma Inc. | SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | Buy | $20.0M |
14 filings